H3N2 and Influenza Group A Viral Load Quantitative Test
At DNA Labs UAE, we offer the H3N2 and Influenza Group A Viral Load Quantitative Test at a cost of AED 2310.0. This diagnostic test is used to measure the amount of H3N2 and Influenza Group A viruses present in a patient’s sample.
Test Details
The H3N2 and Influenza Group A Viral Load Quantitative Test is performed using a technique called real-time polymerase chain reaction (RT-PCR). This method detects and amplifies the viral genetic material, providing important information about the viral load in the body.
Components
- Deep nostrils (nasal swab)
- Nasopharynx (nasopharyngeal swab)
- Nasopharyngeal aspirate
- Throat or bronchial aspirate
Report Delivery
The test results will be delivered via email within 3 working days (36 hours) or over the phone within 24 hours.
Test Type
The H3N2 and Influenza Group A Viral Load Quantitative Test is a viral test performed by a physician in our Genetics department.
Pre Test Information
Prior to the test, patients are required to sign a consent document and bring any relevant clinical history for H3N2 and Influenza Group A Viral Load Quantitative Test.
Importance of the Test
The H3N2 and Influenza Group A Viral Load Quantitative Test is crucial in the diagnosis, management, and prevention of H3N2 and Influenza Group A infections. It provides healthcare professionals with valuable information about the severity of the infection, the effectiveness of antiviral treatments, and the risk of viral transmission to others. This test is particularly useful for high-risk populations, such as immunocompromised individuals or those with underlying health conditions, as it helps healthcare providers make informed decisions about treatment and infection control measures.
By offering the H3N2 and Influenza Group A Viral Load Quantitative Test, DNA Labs UAE aims to provide targeted interventions and improve patient outcomes.
Test Name | H3N2 and Influenza Group A Viral Load Quantitative Test |
---|---|
Components | |
Price | 2310.0 AED |
Sample Condition | Deep nostrils (nasal swab), nasopharynx (nasopharyngeal swab), nasopharyngeal aspirate, throat or bronchial aspirate. |
Report Delivery | 3rd Working Day Email:-36 hours.On phone: 24 hours |
Method | Real Time PCR |
Test type | Viral |
Doctor | Physician |
Test Department: | Genetics |
Pre Test Information | Need to sign Consent document and bring any clinical history of patient forH3N2 & Influenza Group A Viral Load QuantitativeTest |
Test Details |
The H3N2 & Influenza Group A Viral Load Quantitative Test is a diagnostic test used to measure the amount of H3N2 and Influenza Group A viruses present in a patient’s sample, such as nasal or throat swabs. This test is typically performed using a technique called real-time polymerase chain reaction (RT-PCR), which detects and amplifies the viral genetic material. The test is commonly used in clinical settings to diagnose and monitor the progression of H3N2 and Influenza Group A infections. It can provide important information about the viral load, which refers to the amount of virus in the body. The viral load can help healthcare professionals assess the severity of the infection, determine the effectiveness of antiviral treatments, and guide decisions regarding patient management. By quantifying the viral load, this test can also be used to monitor the response to antiviral therapy and to assess the risk of viral transmission to others. It is especially useful in high-risk populations, such as immunocompromised individuals or those with underlying health conditions, as it helps healthcare providers make informed decisions about treatment and infection control measures. Overall, the H3N2 & Influenza Group A Viral Load Quantitative Test plays a crucial role in the diagnosis, management, and prevention of H3N2 and Influenza Group A infections, allowing for targeted interventions and improved patient outcomes. |